Author： Kloft C. Graefe E-U. Tanswell P. Scott A. M. Hofheinz R. Amelsberg A. Karlsson M. O.
Publisher： Springer Publishing Company
ISSN： 0167-6997
Source： Investigational New Drugs, Vol.22, Iss.1, 2004-01, pp. : 39-52
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
By Dirks Nathanael L. Meibohm Bernd
Clinical Pharmacokinetics, Vol. 49, Iss. 10, 2010-10 ,pp. :
Access to resources
Recommend
Improving monoclonal antibody therapies in cancer
Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. :
Monoclonal antibody conjugates in cancer therapy
Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. :
Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 4, 2010-09 ,pp. :